Scarica l'app Stockscreener
21.10
1.49%
-0.2901
Precedente Chiudi:
$21.39
Aprire:
$21.49
Volume 24 ore:
84,476
Relative Volume:
0.18
Capitalizzazione di mercato:
$598.40M
Reddito:
$320.35M
Utile/perdita netta:
$-75.01M
Rapporto P/E:
-8.8089
EPS:
-2.3953
Flusso di cassa netto:
$-113.17M
1 W Prestazione:
+2.69%
1M Prestazione:
+10.03%
6M Prestazione:
-24.77%
1 anno Prestazione:
+9.24%
Intervallo 1D:
$20.85
$21.59
Intervallo di 1 settimana:
$20.42
$21.59
Portata 52W:
$13.46
$31.04
Fulgent Genetics Inc Stock (FLGT) Company Profile
Nome
Fulgent Genetics Inc
Settore
Industria
Telefono
626-350-0537
Indirizzo
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT vs TMO, DHR, IDXX, NTRA, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
21.07 | 592.15M | 320.35M | -75.01M | -113.17M | -2.3953 |
TMO
Thermo Fisher Scientific Inc
|
516.90 | 194.52B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
193.82 | 140.09B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
564.23 | 44.00B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
284.88 | 40.00B | 2.50B | -226.32M | 71.51M | -1.6412 |
WAT
Waters Corp
|
378.25 | 37.24B | 3.77B | 449.25M | 240.68M | 7.8556 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-05 | Aggiornamento | UBS | Neutral → Buy |
| 2023-12-07 | Iniziato | UBS | Neutral |
| 2022-12-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | Iniziato | Raymond James | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-02-04 | Ripresa | Piper Sandler | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Underperform |
| 2021-01-08 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-08-20 | Iniziato | Oppenheimer | Outperform |
| 2020-05-29 | Iniziato | BTIG Research | Buy |
| 2019-11-05 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
Mostra tutto
Fulgent Genetics Inc Borsa (FLGT) Ultime notizie
FLGTFulgent Genetics Inc Forecast, Target Price - Finviz
Enterprise value to EBITDA forward of Fulgent Genetics, Inc. – NASDAQ:FLGT - TradingView
Price to earnings forward of Fulgent Genetics, Inc. – NASDAQ:FLGT - TradingView
Enterprise value to EBIT forward of Fulgent Genetics, Inc. – NASDAQ:FLGT - TradingView
Enterprise value to EBIT forward of Fulgent Genetics, Inc. – BMV:FLGT - TradingView
Enterprise value to revenue forward of Fulgent Genetics, Inc. – NASDAQ:FLGT - TradingView
Price to earnings forward of Fulgent Genetics, Inc. – BMV:FLGT - TradingView
Price to book forward of Fulgent Genetics, Inc. – NASDAQ:FLGT - TradingView
Price to sales forward of Fulgent Genetics, Inc. – BMV:FLGT - TradingView
Fulgent Genetics, Inc. Actuals & Estimates (NASDAQ:FLGT) - TradingView
Fulgent Genetics Inc (FLGT) Valuation: PE, PB & Fair Value Analysis - TradingKey
How (FLGT) Movements Inform Risk Allocation Models - Stock Traders Daily
Fulgent Genetics, Inc. Actuals & Estimates (BMV:FLGT) - TradingView
FLGT Forecast — Price Target — Prediction for 2027 - TradingView
Fulgent Genetics, Inc. Actuals & Estimates (BIVA:FLGT) - TradingView
Fulgent Genetics (FLGT) Stock Faces Mixed Analyst Target Changes After Margin Questions - Yahoo Finance
Fulgent Genetics Inc (FLGT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Fulgent Genetics Inc (FLGT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Fulgent Genetics Inc (FLGT) Institutional Confidence - TradingKey
Fulgent Genetics Inc (FLGT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Fulgent Genetics Inc (FLGT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Fulgent Genetics Inc. (FLGT) Q1 2026 Earnings: EPS Miss Widens, Yet Shares Buck the TrendEarnings Cycle Report - Město Břeclav
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022. - marketscreener.com
Fulgent Genetics Inc (FLGT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Fulgent Genetics Inc (FLGT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Fulgent Genetics Inc (FLGT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Fulgent Genetics unveils FulGenome upgrade with higher repeat expansion detection - Traders Union
Trading Systems Reacting to (FLGT) Volatility - Stock Traders Daily
Fulgent Deadline Alert - TMX Newsfile
How The Fulgent Genetics (FLGT) Investment Story Is Evolving With Recent Developments - Yahoo Finance
Fulgent Genetics Inc. (FLGT) Q1 2026 Earnings: Wide EPS Miss Sends Shares LowerEarnings Acceleration Picks - dars.gov.et
Fulgent Genetics CSO Gao Hanlin sells $30,190 in stock By Investing.com - Investing.com Australia
How Fulgent Genetics Inc. (FLGT) Affects Rotational Strategy Timing - Stock Traders Daily
Fulgent Genetics CSO Gao Hanlin sells $30,190 in stock - Investing.com
Fulgent Genetics (NASDAQ: FLGT) insider sale covers RSU taxes - Stock Titan
Fulgent Genetics (FLGT) CFO reports tax withholding of vested RSU shares - Stock Titan
Fulgent Genetics (FLGT) CSO sells 1,688 shares to cover RSU tax - Stock Titan
Fulgent (NASDAQ: FLGT) CEO RSU vest triggers 4,392-share tax withholding - Stock Titan
Fulgent Genetics (NASDAQ: FLGT) Form 144 lists 45,304 vested shares; small prior sale - Stock Titan
Fulgent Presents Updated Phase 2 FID-007 + Cetuximab Data at ASCO Showing 61.9% ORR - TradingView
Fulgent Genetics (FLGT) Presents Promising Data on Head and Neck Cancer Treatment - GuruFocus
Strong FID-007 Phase 2 results for Fulgent Genetics (NASDAQ: FLGT) - Stock Titan
Fulgent Presents Updated FID-007 Data at ASCO 2026 - The Joplin Globe
FLGT Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin, Stock DeclinesEstimate Accuracy - dars.gov.et
Fulgent Genetics COO Jian Xie sells $21,137 in company stock By Investing.com - Investing.com Australia
Fulgent Genetics COO Jian Xie sells $21,137 in company stock - Investing.com
Fulgent Genetics (NASDAQ: FLGT) exec sells shares for tax withholding - Stock Titan
[Form 4] Fulgent Genetics, Inc. Insider Trading Activity - Stock Titan
Fulgent Genetics (FLGT) CSO sells 945 shares to cover tax obligations - Stock Titan
Ming Hsieh (FLGT) reports 32% Fulgent Genetics stake and major share pledges - Stock Titan
Fulgent Genetics (FLGT) CEO reports RSU tax withholding and large trust holdings - Stock Titan
Fulgent Genetics Inc Azioni (FLGT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Fulgent Genetics Inc Azioni (FLGT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Gao Hanlin | Chief Scientific Officer |
Jun 02 '26 |
Sale |
17.89 |
1,688 |
30,191 |
990,374 |
1.03%
0.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):